Open an account

Twist Bioscience

TWST · NASDAQ

$142.70+$2.93 (+2.10%)TodayMarket closed ·
Prev close $139.77

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 979 full-time employees. The company went IPO on 2018-10-31. The firm's proprietary silicon-based platform delivers precision, scale, and speed, supporting consistent, high-quality performance across a range of applications. The Company’s platform is a differentiated method of manufacturing synthetic deoxyribonucleic acid (DNA) by writing DNA on a silicon chip. By integrating proprietary hardware, software, and scalable infrastructure, including its e-commerce platform. The firm has extended this platform beyond DNA synthesis to offer an integrated portfolio that includes synthetic genes, next-generation sequencing, applications, sample preparation tools, antibody libraries, and biologic discovery services. Leveraging the same platform, it also manufactures synthetic ribonucleic acid (RNA) and expresses antibody proteins.

Employees
979
Headquarters
South San Francisco, California
Listed
Oct 31, 2018
Sector
Health Care
Industry
Biotechnology
Website
twistbioscience.com

TWST key statistics

Market cap
9.20B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.24M
Volume
1.45M
Open price
$139.77
High today
$148.83
Low today
$134.94
52 Week high
$219.71
52 Week low
$23.30

Twist Bioscience (TWST) at a glance

As of Oct 20, 2026, Twist Bioscience (TWST) shares are priced at $142.70, giving the company a market cap of 9.20B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $134.94 and $148.83. The current price is 5.8% above the day's low and 4.1% below its high.

Volume so far is 1.45M shares, below the average of 3.24M shares a day.

Over the past year Twist Bioscience has ranged from $23.30 to $219.71, and now sits 61% of the way up that range.

Twist Bioscience met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.56 per share against an estimate of -$0.5036.

The average analyst price target is $118.60, 16.9% below the current price, from 12 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

67%of 12 analyst ratings say Buy
  • Buy66.7%
  • Hold25.0%
  • Sell8.3%
Price target · 13 analystsAvg $118.60
Low
$45.45
Now
$142.70
High
$168.00

TWST earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 18.1% on average.

  1. Q3 FY24: reported -$1.47 per share against an estimate of -$0.7805
  2. Q4 FY24: reported -$0.59 per share against an estimate of -$0.7244
  3. Q1 FY25: reported -$0.53 per share against an estimate of -$0.6475
  4. Q2 FY25: reported -$0.66 per share against an estimate of -$0.5873
  5. Q3 FY25: reported -$0.47 per share against an estimate of -$0.5699
  6. Q4 FY25: reported -$0.45 per share against an estimate of -$0.4378
  7. Q1 FY26: reported -$0.59 per share against an estimate of -$0.4869
  8. Q2 FY26: reported -$0.56 per share against an estimate of -$0.5036

TWST news

  • 10 Health Care Stocks With Whale Alerts In Today’s Session

  • Avi Kapoor

    Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday

  • Chandrima Sanyal

    Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

  • Rishabh Mishra

    Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison’

  • Press releasePRNewswire

    AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

  • Evette Mitkov

    Twist Bioscience Stock Hits New High, Then Retreats: What's Happening?

  • Vandana Singh

    Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem

  • Press releaseBusiness Wire

    Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

Similar companies

Companies in the same industry as Twist Bioscience

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.